The World Federation of Nuclear Medicine and Biology (WFNMB) is the peak global nuclear medicine organisation, and is the principal body for promotion of nuclear medicine and linkage of countries where nuclear medicine is practised. The WFNMB provides strong advocacy for nuclear medicine with international organisations (eg WHO, IAEA), as well as providing co-ordinating projects aimed at improving access and availability of molecular imaging and therapy procedures in developed and developing countries.
A key strategic goal of the WFNMB is to provide a forum for establishing standards of training and practise, and evidence based use, that are global in context and implementation. The WFNMB is also implementing a program for supporting emerging leaders in nuclear medicine from all regions of the world. The leadership provided by the WFNMB will continue to enhance the contribution of nuclear medicine to the health and wellbeing of patients in a global context.
Andrew Scott,
The WFNMB quadrennial Congresses is considered as the "Olympics of Nuclear Medicine Conferences", and has become a major international forum for the presentation of all aspects nuclear medicine basic, applied and clinical nuclear medicine research, diagnosis and treatment of various disorders. The evolution of nuclear medicine practice has resulted in the integration of hybrid imaging into the program of this caliber of meetings, and a multidisciplinary approach in this era of personalized medicine.
The 12th Congress of the WFNMB will be held from the 20th to 24th of April, 2018 in Melbourne, Australia. The theme of this congress is to promote "Global Translation of Molecular Medicine", incorporating the translation of basic laboratory research to clinical practice, establishment of clinical and technical standards, and the translation of molecular medical technology to developing countries for the benefit of patients worldwide. This Congress will celebrate the advances of nuclear medicine globally and with over 100 internationally renowned speakers, including two Nobel Laureates, promises to be one of the most memorable events in the Nuclear Medicine calendar of 2018.
Sze-Ting Lee,
I am Dong Soo Lee from Korea, a small but rapidly innovating country.
Just twenty years ago, we Koreans have started Nuclear Medicine as an independent discipline and have successfully caught up with the global standards of clinical practice and scientific achievements in this field...
Dong Soo Lee,
For the agency, the World Federation is an extremely important partner, delivering education into developing regions, which is similar to our aims. Synergies in our ...
Diana Paez,
AOFNMB launched in 1969 consisting of 74 member states of Oceania, West Asia, Central Asia, South Asia, South East Asia, and North East Asia to promote nuclear medicine practice in the region. Demand for expertise in nuclear medicine and related sciences is now increasing rapidly and steadily. Competent, well trained and properly qualified human resources are vital to sustaining safe and efficient nuclear medicine. There is a need to deliver systematic, sustainable, harmonized and standardized training; and to improve quality, efficiency and effectiveness in nuclear medicine professional human resource development. AOFNMB is such a platform to promote nuclear medicine practice in the region. WFNMB is global body having same direction with more extensive network for human resource development of nuclear medicine professionals. We work together for the future of nuclear medicine.
Jun Hatazawa,
The world federation is the appropriate body for developing and developed countries to converge their efforts to expand clinical nuclear medicine in the benefit of the patient and research.
Salah Eddine Bouyoucef,
The Australian & New Zealand Society of Nuclear Medicine (ANZSNM) is proud to have been selected to host the 12th World Congress of the WFNMB in 2018 in Melbourne. We are particularly delighted as it will coincide with the 50th anniversary of the founding of our Society. Our Society has a membership of over 800 and includes all professionals involved in delivering health care services in nuclear medicine. In recent years we have increasingly embraced new technologies as early adopters and, due to a favourable regulatory environment, can initiate clinical imaging trials in a timely and efficient manner, providing us with early access to new procedures.
Prof Andrew Scott & his team have managed to engage some of the most outstanding clinicians, researchers, innovators, educators, practitioners and visionaries that the field of nuclear medicine has to offer to come to Melbourne and share their knowledge and experience with us.
If ever there was to be a great time to host a World Congress in Nuclear Medicine it must surely be now.
Surely, we are experiencing the most exciting time in the field for the past 25 years or more. Whether it be new detectors and hybrid imaging devices, new molecular targets and diagnostic strategies, new radiopharmaceuticals, alpha particles and new beta-emitters for interventions and therapies, and new methods for delivering training and education, it is a time of great innovation and disruption in nuclear medicine.
The Congress will be followed by a Post-Congress Symposium in Cairns on the Great Barrier Reef with an outstanding programme of invited speakers focussed on our emerging/erupting role in prostate cancer management, along with plenty of opportunities to enjoy the balmy tropical "Deep North" of Australia.
The world is getting smaller and getting to Australia has never been easier.
Please, do join us. Don't miss out.
Dale L Bailey,
Vijay Kumar,
The focus of WFNMB conference is to promote the State of the Art and Future of Nuclear Medicine globally. The executive committee has been working hard to make it truly global and has seen more participation from the global community. The World Federation of Nuclear Medicine and Biology (WFNMB) organizes a quadrennial Congress which is the third largest nuclear medicine conference worldwide, behind the European (EANM) & American (SNMMI) nuclear medicine conferences.
The 12th WFNMB conference will be held in Melbourne from 20-24th April 2018. The venue for the Congress is the state-of-the-art Melbourne Convention and Exhibition Centre. Visit the webpage to see more details: https://wfnmb2018. com/ The congress is organized with global community in mind and your participation is the best way to complement all our efforts. Take advantage of this mega-event organized down under, and come and see the galaxy of international experts, including two Nobel Laureates, Professor Brian Schmidt, Nobel Laureate in Physics 2011 and Professor Peter Doherty Nobel Laureate in Medicine 1996, perform their best to satisfy your scientific appetite. Be assured of extra-scientific activities during the course of the conference to satisfy your aesthetic aspects as well.
The Asian Regional Cooperative Council for Nuclear Medicine (ARCCNM) started in 2001 to establish liaisons with the official national bodies of nuclear medicine and to enhance regional scientific activities. ARCCNM has 18 member states in east, south-east, and south Asia. ARCCNM has held annual general meetings associated with national or international meetings throughout the region. One of the key activities of ARCCNM is promotional programmes for young nuclear medicine professionals in developing countries. ARCCNM acknowledges the importance of governmental support especially in developing countries, and makes efforts to communicate between nuclear medicine communities and governments of member states. ARCCNM is closely work with the regional office of the Regional Cooperative Agreement (RCA), the Asian School of Nuclear Medicine (ASNM) and the Asian Nuclear Medicine Board (ANMB) committee.
Hee-Seung Bom,